Skip to main content

Precigen, Inc.

PGEN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001356090

In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 6 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.4M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Precigen, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
179
+17 vs. Q3 2025
Shares held
136.0M
+25.5M (+23.0%) vs. Q3 2025
Total value
$568.5M
+$204.8M (+56.3%) vs. Q3 2025
New holders
36
78 more added
Sold out
19
32 more reduced

5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 179 institutions
Q1 2021: 166 institutionsQ2 2021: 150 institutionsQ3 2021: 172 institutionsQ4 2021: 168 institutionsQ1 2022: 173 institutionsQ2 2022: 169 institutionsQ3 2022: 165 institutionsQ4 2022: 161 institutionsQ1 2023: 157 institutionsQ2 2023: 138 institutionsQ3 2023: 138 institutionsQ4 2023: 137 institutionsQ1 2024: 129 institutionsQ2 2024: 130 institutionsQ3 2024: 127 institutionsQ4 2024: 133 institutionsQ1 2025: 138 institutionsQ2 2025: 147 institutionsQ3 2025: 167 institutionsQ4 2025: 179 institutionsQ1 2026: 206 institutionsQ2 2026: 210 institutions
Value heldQ4 2025: $568.5M
Q1 2021: $978.6MQ2 2021: $926.2MQ3 2021: $690.3MQ4 2021: $529.9MQ1 2022: $302.8MQ2 2022: $182.2MQ3 2022: $265.0MQ4 2022: $64.3MQ1 2023: $65.1MQ2 2023: $66.0MQ3 2023: $86.0MQ4 2023: $83.9MQ1 2024: $89.4MQ2 2024: $95.9MQ3 2024: $71.7MQ4 2024: $84.8MQ1 2025: $119.3MQ2 2025: $116.6MQ3 2025: $366.2MQ4 2025: $568.5MQ1 2026: $516.7MQ2 2026: $799.4M
Institutions holding PGEN and their total value by quarter
QuarterHoldersValue
Q2 2026210$799.4M
Q1 2026206$516.7M
Q4 2025179$568.5M
Q3 2025167$366.2M
Q2 2025147$116.6M
Q1 2025138$119.3M
Q4 2024133$84.8M
Q3 2024127$71.7M
Q2 2024130$95.9M
Q1 2024129$89.4M
Q4 2023137$83.9M
Q3 2023138$86.0M
Q2 2023138$66.0M
Q1 2023157$65.1M
Q4 2022161$64.3M
Q3 2022165$265.0M
Q2 2022169$182.2M
Q1 2022173$302.8M
Q4 2021168$529.9M
Q3 2021172$690.3M
Q2 2021150$926.2M
Q1 2021166$978.6M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Precigen, Inc.; share changes are against Q3 2025.

Institutions holding PGEN in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 (DIFC) Ltd––––Not filed
CIBC Bancorp USA Inc.––––Not filed
Point72 Asia (Singapore) Pte. Ltd.––––Not filed